These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30186117)

  • 1. Dichotomous Dopaminergic Control of Ventral Pallidum Neurons.
    Clark M; Bracci E
    Front Cell Neurosci; 2018; 12():260. PubMed ID: 30186117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.
    Nimitvilai S; Herman M; You C; Arora DS; McElvain MA; Roberto M; Brodie MS
    Neuropharmacology; 2014 Jul; 82():28-40. PubMed ID: 24657149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion.
    Peczely L; Ollmann T; Laszlo K; Lenard L; Grace AA
    Int J Neuropsychopharmacol; 2022 Aug; 25(7):590-599. PubMed ID: 35348731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons.
    Alberto CO; Trask RB; Quinlan ME; Hirasawa M
    J Neurosci; 2006 Sep; 26(39):10043-50. PubMed ID: 17005867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.
    Nimitvilai S; Brodie MS
    J Pharmacol Exp Ther; 2010 May; 333(2):555-63. PubMed ID: 20164301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens.
    Yang CR; Mogenson GJ
    Brain Res; 1989 Jun; 489(2):237-46. PubMed ID: 2568154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Electrical Stimulation of NAc Afferents on VP Neurons' Tonic Firing.
    Clark M
    Front Cell Neurosci; 2020; 14():599920. PubMed ID: 33328895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels.
    Congar P; Bergevin A; Trudeau LE
    J Neurophysiol; 2002 Feb; 87(2):1046-56. PubMed ID: 11826068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J; Dougherty JJ; Nichols RA
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamatergic Ventral Pallidal Neurons Modulate Activity of the Habenula-Tegmental Circuitry and Constrain Reward Seeking.
    Tooley J; Marconi L; Alipio JB; Matikainen-Ankney B; Georgiou P; Kravitz AV; Creed MC
    Biol Psychiatry; 2018 Jun; 83(12):1012-1023. PubMed ID: 29452828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.
    Robertson GS; Jian M
    Neuroscience; 1995 Feb; 64(4):1019-34. PubMed ID: 7753373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
    André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
    Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.